Fudan University

Asieris Appoints Dr. Linda Wu as Chief Development Officer

Retrieved on: 
Tuesday, January 17, 2023

SHANGHAI, Jan. 17, 2023 /PRNewswire/ -- Asieris Pharmaceuticals(688176.SH), a global biopharma company specializing in discovering, developing and commercializing innovative drugs for the treatment of genitourinary tumors and other related diseases, announced that Linda Wu, Ph.D. will join Asieris as Chief Development Officer today, effective January 17, 2023.

Key Points: 
  • SHANGHAI, Jan. 17, 2023 /PRNewswire/ -- Asieris Pharmaceuticals(688176.SH), a global biopharma company specializing in discovering, developing and commercializing innovative drugs for the treatment of genitourinary tumors and other related diseases, announced that Linda Wu, Ph.D. will join Asieris as Chief Development Officer today, effective January 17, 2023.
  • Dr. Wu will be based in the United States and report to Dr. Kevin Pan, Founder, Chairman and CEO of Asieris.
  • Dr. Wu joins Asieris from Janssen Pharmaceuticals, a Johnson & Johnson company, where she most recently served as a Group Medical Director of Oncology, US Medical Affairs.
  • "I am thrilled and deeply honored to be appointed as Chief Development Officer at Asieris.

Breast Milk Storage Products Market Size, Share & Trends Analysis Report 2022: A Global $834.06 Million Market by 2030 - Expanding Milk Banks are Predicted to Significantly Increase the Demand - ResearchAndMarkets.com

Retrieved on: 
Monday, January 16, 2023

The global breast milk storage products market size is expected to reach USD 834.06 million by 2030, expanding at a CAGR of 8.28% from 2022 to 2030.

Key Points: 
  • The global breast milk storage products market size is expected to reach USD 834.06 million by 2030, expanding at a CAGR of 8.28% from 2022 to 2030.
  • The expansion of the market for breast milk storage products can be attributed to growing public knowledge of the advantages of breast milk.
  • Globally expanding milk banks are predicted to significantly increase the demand for breast milk storage products including bottles and bags.
  • This is expected to increase the milk donation, thereby impelling the need for breast milk storage products.

Columbus McKinnon Appoints Rebecca Yeung to Board of Directors

Retrieved on: 
Monday, January 9, 2023

Columbus McKinnon Corporation (Nasdaq: CMCO), a leading designer, manufacturer and marketer of intelligent motion solutions for material handling, today announced the appointment of Rebecca Yeung, Corporate VP, Operations Science & Advanced Technology, FedEx Corporation (NYSE: FDX) to its Board of Directors, effective January 9, 2023.

Key Points: 
  • Columbus McKinnon Corporation (Nasdaq: CMCO), a leading designer, manufacturer and marketer of intelligent motion solutions for material handling, today announced the appointment of Rebecca Yeung, Corporate VP, Operations Science & Advanced Technology, FedEx Corporation (NYSE: FDX) to its Board of Directors, effective January 9, 2023.
  • The addition of Ms. Yeung as an independent director brings Columbus McKinnon's Board to eleven directors of which ten are independent.
  • View the full release here: https://www.businesswire.com/news/home/20230109005834/en/
    Columbus McKinnon Appoints Rebecca Yeung to Board of Directors (Photo: Business Wire)
    Richard H. Fleming, Chairman of the Board, commented "We are very excited to welcome Rebecca to our Board.
  • Ms. Yeung brings to the Board nearly 30 years of global experience in both strategy and operations technology.

Junshi Biosciences Announces NEJM Publication of Results of Phase 3 Study of VV116 Versus PAXLOVID for Adults at High Risk for Progression to Severe COVID-19

Retrieved on: 
Thursday, December 29, 2022

It is the first time that NEJM published the clinical trial results of China-developed anti-SARS-CoV-2 drug.

Key Points: 
  • It is the first time that NEJM published the clinical trial results of China-developed anti-SARS-CoV-2 drug.
  • The results indicated that the primary endpoint of the study realized the designed noninferiority endpoint, and VV116 group had a shorter time to sustained clinical recovery with less safety concerns as compared with PAXLOVID.
  • Finally, a total of 771 patients (Full Analysis Set, FAS) were treated with VV116 (n = 384) or PAXLOVID (n = 387).
  • The incidence of AEs in VV116 group was lower than that in the PAXLOVID group (all-grade AEs: 67.4% vs. 77.3%, Grade 3 or 4 AE: 2.6% vs. 5.7%).

Antelope Enterprise Appoints Weilai 'Will' Zhang as New CEO

Retrieved on: 
Thursday, January 5, 2023

Ms. Meishuang Huang has departed from her role as CEO but will remain as Chair of the Board of Directors.

Key Points: 
  • Ms. Meishuang Huang has departed from her role as CEO but will remain as Chair of the Board of Directors.
  • "I am honored and excited to serve as Antelope Enterprise's CEO at this time when the Company is on the cusp of transforming itself into a pure play in the rapidly emerging social ecommerce market in China," said Weilai ('Will') Zhang.
  • Will Zhang brings extensive entrepreneurial, venture capital and investment management experience to his new role.
  • Since 2020, Mr. Zhang has acted as Chairman of Jinke Yulv Technology Ltd., an internet technology firm in China.

Zhihu Inc. Appoints New Director and Chief Financial Officer

Retrieved on: 
Monday, January 2, 2023

BEIJING, Jan. 2, 2023 /PRNewswire/ -- Zhihu Inc. ("Zhihu" or the "Company") (NYSE: ZH; HKEX: 2390), the operator of Zhihu, a leading online content community in China, today announced that its board of directors has appointed Mr. Henry Dachuan Sha as a Director and the Chief Financial Officer of the Company, effective immediately.

Key Points: 
  • BEIJING, Jan. 2, 2023 /PRNewswire/ -- Zhihu Inc. ("Zhihu" or the "Company") (NYSE: ZH; HKEX: 2390), the operator of Zhihu, a leading online content community in China, today announced that its board of directors has appointed Mr. Henry Dachuan Sha as a Director and the Chief Financial Officer of the Company, effective immediately.
  • Mr. Sha will replace Mr. Wei Sun, who has tendered his resignation from the positions of director and chief financial officer to pursue other business endeavors.
  • Prior to joining Zhihu, Mr. Sha served as the Chief Financial Officer of Quwan Holding Limited between October 2020 and December 2022.
  • From September 2017 to December 2019, Mr. Sha served as the Chief Financial Officer of Huya Inc. (NYSE: HUYA).

CGTN: New Approaches: Why China is easing its COVID-19 curbs now

Retrieved on: 
Tuesday, December 20, 2022

By November when China announced its new policies to relax a series of stringent measures meant to monitor and cut the spread of COVID-19, the country had reported over 5,000 deaths caused by this virus.

Key Points: 
  • By November when China announced its new policies to relax a series of stringent measures meant to monitor and cut the spread of COVID-19, the country had reported over 5,000 deaths caused by this virus.
  • The low death toll, out of a population of 1.4 billion, did not come easily.
  • As many countries tried and gave up stricter measures one after another in the past three years, China didn't follow.
  • Data showed that Omicron replicates to lower levels than the Delta in rhesus macaques, resulting in reduced clinical disease.

CGTN: New Approaches: Why China is easing its COVID-19 curbs now

Retrieved on: 
Tuesday, December 20, 2022

By November when China announced its new policies to relax a series of stringent measures meant to monitor and cut the spread of COVID-19, the country had reported over 5,000 deaths caused by this virus.

Key Points: 
  • By November when China announced its new policies to relax a series of stringent measures meant to monitor and cut the spread of COVID-19, the country had reported over 5,000 deaths caused by this virus.
  • The low death toll, out of a population of 1.4 billion, did not come easily.
  • As many countries tried and gave up stricter measures one after another in the past three years, China didn't follow.
  • Data showed that Omicron replicates to lower levels than the Delta in rhesus macaques, resulting in reduced clinical disease.

Global Times survey: over 60% participants believe China's global influence rising; world concern war, energy & foods crises more than pandemic

Retrieved on: 
Monday, December 19, 2022

Analysts said the survey reflects that the world welcomes and has strong confidence in China's development and Chinese modernization.

Key Points: 
  • Analysts said the survey reflects that the world welcomes and has strong confidence in China's development and Chinese modernization.
  • more than 30 percent among all participants worldwide believe the US' influence is rising, while a similar number of participants believe the US' influence is declining.
  • In countries like Kenya, South Africa, Nigeria, Austria, Poland and India, more people believe that the US' influence is rising rather than declining.
  • In the US, 32 percent of participants believe their country's international influence is rising while another 32 percent believe the US' influence is declining, while 56 percent believe China's influence is rising.

CGTN: 'New Approaches': Hospitals gear up to prioritize COVID-19 patients

Retrieved on: 
Wednesday, December 14, 2022

The measures require enhancing medical resources to prioritize COVID-19 patients.

Key Points: 
  • The measures require enhancing medical resources to prioritize COVID-19 patients.
  • To avoid panic and a squeeze on medical resources, local governments and hospitals are upgrading existing temporary hospitals, adding ICU beds and better distributing medical resources.
  • China built temporary hospitals to receive and treat COVID-19 patients with mild symptoms and cut off the spread of the virus.
  • "We have set up different areas and provided different channels for different groups of patients to ensure all the patients can receive medical care timely.